Literature DB >> 19603119

Filling the gap in LNA antisense oligo gapmers: the effects of unlocked nucleic acid (UNA) and 4'-C-hydroxymethyl-DNA modifications on RNase H recruitment and efficacy of an LNA gapmer.

Kees Fluiter1, Olaf R F Mook, Jeroen Vreijling, Niels Langkjaer, Torben Højland, Jesper Wengel, Frank Baas.   

Abstract

Stability against nucleases, affinity for the targeted mRNA and the ability to recruit RNase H are prerequisites for antisense oligonucleotide (AON) applications where gene expression knockdown is required. Typically chimeric gapmer AON designs are used with a central continuous stretch of RNase H recruiting nucleotides (e.g. phosphorothioate DNA), flanked by affinity and stability-enhancing modified nucleotides. However, many types of nucleotide modifications in the central DNA gap can disturb RNase H function. Here we present studies into two different types of nucleotide modifications, a flexible acyclic RNA analog named unlocked nucleic acid (UNA) and 4'-C-hydroxymethyl-DNA in the gap of an LNA (locked nucleic acid) flanked gapmer. We compared the efficacy of mRNA degradation by the gap modified LNA antisense gapmers in cell-free assays and cultured cells. This study shows that both UNA and 4'-C-hydroxymethyl-DNA gap insertions are compatible with RNase H activity when used sparingly. However, multiple 4'-C-hydroxymethyl-DNA modifications are better tolerated by RNase H than multiple UNA modifications in the gap. Furthermore, this report shows that LNA gapmer AONs with multiple 4'-C-hydroxymethyl-DNA moieties in the gap can mediate target knockdown in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19603119     DOI: 10.1039/b903922h

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  14 in total

Review 1.  Noncoding RNAs in the Regulatory Network of Hypertension.

Authors:  Gengze Wu; Pedro A Jose; Chunyu Zeng
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

2.  Hiding in the Shadows: CPOX Expression and 5-ALA Induced Fluorescence in Human Glioma Cells.

Authors:  Nikolay Pustogarov; Dmitriy Panteleev; Sergey A Goryaynov; Anastasia V Ryabova; Ekaterina Y Rybalkina; Alexander Revishchin; Alexander A Potapov; Galina Pavlova
Journal:  Mol Neurobiol       Date:  2016-09-19       Impact factor: 5.590

3.  Thermodynamics of RNA duplexes modified with unlocked nucleic acid nucleotides.

Authors:  Anna Pasternak; Jesper Wengel
Journal:  Nucleic Acids Res       Date:  2010-06-18       Impact factor: 16.971

4.  Improved thrombin binding aptamer by incorporation of a single unlocked nucleic acid monomer.

Authors:  Anna Pasternak; Frank J Hernandez; Lars M Rasmussen; Birte Vester; Jesper Wengel
Journal:  Nucleic Acids Res       Date:  2010-09-24       Impact factor: 16.971

5.  Thermodynamic contributions of single internal rA·dA, rC·dC, rG·dG and rU·dT mismatches in RNA/DNA duplexes.

Authors:  Norman E Watkins; William J Kennelly; Mike J Tsay; Astrid Tuin; Lara Swenson; Hyung-Ran Lee; Svetlana Morosyuk; Donald A Hicks; John Santalucia
Journal:  Nucleic Acids Res       Date:  2010-11-10       Impact factor: 16.971

Review 6.  Oligonucleotide Therapies: The Past and the Present.

Authors:  Karin E Lundin; Olof Gissberg; C I Edvard Smith
Journal:  Hum Gene Ther       Date:  2015-08-03       Impact factor: 5.695

Review 7.  Drugs in Development for Hepatitis B.

Authors:  Altaf Dawood; Syed Abdul Basit; Mahendran Jayaraj; Robert G Gish
Journal:  Drugs       Date:  2017-08       Impact factor: 9.546

Review 8.  Non-coding RNA therapeutics for cardiac regeneration.

Authors:  Luca Braga; Hashim Ali; Ilaria Secco; Mauro Giacca
Journal:  Cardiovasc Res       Date:  2021-02-22       Impact factor: 10.787

Review 9.  The Function and Therapeutic Potential of Long Non-coding RNAs in Cardiovascular Development and Disease.

Authors:  Clarissa P C Gomes; Helen Spencer; Kerrie L Ford; Lauriane Y M Michel; Andrew H Baker; Costanza Emanueli; Jean-Luc Balligand; Yvan Devaux
Journal:  Mol Ther Nucleic Acids       Date:  2017-07-28       Impact factor: 8.886

10.  Locked Nucleic Acid Gapmers and Conjugates Potently Silence ADAM33, an Asthma-Associated Metalloprotease with Nuclear-Localized mRNA.

Authors:  Hannah M Pendergraff; Pranathi Meda Krishnamurthy; Alexandre J Debacker; Michael P Moazami; Vivek K Sharma; Liisa Niitsoo; Yong Yu; Yen Nee Tan; Hans Michael Haitchi; Jonathan K Watts
Journal:  Mol Ther Nucleic Acids       Date:  2017-06-21       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.